Internet-delivered lifestyle physical activity intervention for cognitive processing speed in multiple sclerosis

Motl, Robert W.; Sandroff, Brian M.; Benedict, Ralph H. B.; Aldunate, Roberto; Cutter, Gary; Barron, Emily

Abstract

Background: We propose a randomized controlled trial(RCT) of a Social Cognitive Theory-based(SCT), Internetdelivered behavioral intervention targeting lifestyle physical activity(LPA) for yielding improvements in cognitive processing speed(CPS), learning and memory(L/M), symptoms, and quality of life(QOL) among persons with mild multiple sclerosis(MS)-related ambulatory impairment who have impaired CPS. Methods/design: The study involves a Phase-II, parallel group, RCT design. Participants with MS(N = 300) will be randomly assigned on an equal basis(1:1) into behavioral intervention(n = 150) or attention and social contact control(n = 150) conditions. The conditions will be administered over 6-months by trained behavior coaches who will be uninvolved in screening, recruitment, random assignment, and outcome assessment. We will collect outcome data remotely every 6-months over the 12-month period(baseline, immediate follow-up, and 6-month follow-up) using a treatment blinded assessor. The primary outcome is the raw, oral Symbol Digit Modalities Test as a neuropsychological measure of CPS. The secondary outcomes include the California Verbal Learning Test-II as an objective measure of L/M, and patient-reported outcomes of fatigue, depressive symptoms, anxiety, pain, and QOL. The tertiary outcome is accelerometry as an objective, device-based measure of steps/day for generating a minimal clinically important difference(MCID) value that guides the prescription of LPA for improving CPS in clinical practice. The primary data analyses will involve intent-to-treat principles, and mixed-effects models and logistic regression. Discussion: If successful, the proposed study will provide Class I evidence for the efficacy of a theory-based, Internet-delivered behavioral intervention focusing on LPA for improving CPS and mitigating its negative impact on other outcomes in persons with MS. Clinicaltrials.gov: NCT04518657

Más información

Título según WOS: ID WOS:001176824500001 Not found in local WOS DB
Título de la Revista: CONTEMPORARY CLINICAL TRIALS
Volumen: 138
Editorial: Elsevier Science Inc.
Fecha de publicación: 2024
DOI:

10.1016/j.cct.2024.107446

Notas: ISI